- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07601308
Impact of Online Medical Misinformation
May 15, 2026 updated by: Mohamed Fakhry Ahmed Salem, Alexandria University
Impact of Online Medical Misinformation on Medication Adherence, Treatment Decisions, and Health-Seeking Behavior Among Patients With Chronic Diseases
This mixed-methods study aims to examine the impact of exposure to online medical misinformation on medication adherence, treatment decision-making, and healthcare-seeking behavior among patients with chronic diseases.
The study targets patients with hypertension, diabetes mellitus, and dyslipidemia and evaluates how misinformation influences real-world health behaviors.
Quantitative and qualitative data will be collected concurrently to provide a comprehensive understanding of misinformation-related health risks.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed Fakhry Ahmed Salem, PhD
- Phone Number: +201286038014
- Email: Mohamed.Fakhry@alexu.edu.eg
Study Contact Backup
- Name: Ahmed Salem
- Email: Mohamed.Fakhry@alexu.edu.eg
Study Locations
-
-
-
Alexandria, Egypt, 21511
- Faculty of Nursing, Alexandria University
-
Contact:
- Mohamed Fakhry
- Phone Number: 01286038014
- Email: Mohamed.Fakhry@alexu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult patients with chronic diseases attending outpatient clinics, who actively use social media and are exposed to online medical information.
Description
Inclusion Criteria:
- Adults ≥ 18 years
- Disease duration ≥ 6 months
- Social media use at least once weekly
- Able to provide informed consent
Exclusion Criteria:
- Severe cognitive or psychiatric disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Single Cohort: Adults With Chronic Diseases Exposed to Online Medical Information
|
None (observational)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication Adherence (MARS-5 Score)
Time Frame: At baseline survey assessment
|
Description: Measures adherence to prescribed medications
|
At baseline survey assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Susceptibility to Medical Misinformation (OMISS Score)
Time Frame: At baseline survey assessment
|
Measures verification behavior toward online medical information
|
At baseline survey assessment
|
|
Treatment Decision Changes (OHIU-CD Subscale)
Time Frame: At baseline survey assessment
|
Measures changes in treatment decisions influenced by online information
|
At baseline survey assessment
|
|
Healthcare-Seeking Behavior Score
Time Frame: At baseline survey assessment
|
At baseline survey assessment
|
|
|
Qualitative Themes of Misinformation Impact
Time Frame: At baseline survey assessment
|
At baseline survey assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Mohamed Fakhry Ahmed Salem, PHD, Alexandria University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 15, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
May 9, 2026
First Submitted That Met QC Criteria
May 15, 2026
First Posted (Actual)
May 22, 2026
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 15, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Disease Attributes
- Metabolic Diseases
- Glucose Metabolism Disorders
- Pathological Conditions, Signs and Symptoms
- Behavior
- Nutritional and Metabolic Diseases
- Treatment Adherence and Compliance
- Patient Compliance
- Patient Acceptance of Health Care
- Hypertension
- Diabetes Mellitus
- Chronic Disease
- Health Behavior
- Medication Adherence
Other Study ID Numbers
- IRB00013620_MisinformationStud
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Adherence
-
NYU Langone HealthRobert Wood Johnson Foundation; New York City Health and Hospitals CorporationCompletedMedication Adherence | Medication ErrorsUnited States
-
Universidad Autonoma de Baja CaliforniaCompletedMedication Adherence | Medication ComplianceMexico
-
Vanderbilt University Medical CenterCompletedAdherence, Medication | Nonadherence, MedicationUnited States
-
Universiti Putra MalaysiaCompletedMedication Adherence | Adherence, TreatmentPakistan
-
University Hospital, Basel, SwitzerlandUniversity of BaselCompletedPolymedication-Check With Insight in Patients' Medication Organisation and Comprehension of GenericsMedication Adherence | Medication Therapy ManagementSwitzerland
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Sir Halley Stewart TrustCompletedMedication Adherence | Medication Compliance | Attitude | CaregiversUnited Kingdom
-
National Healthcare Group, SingaporeCompletedMedication Adherence | Medication Administered in Error
-
Cliniques universitaires Saint-Luc- Université...RecruitingAdherence, MedicationBelgium
-
Swedish Medical CenterNational Institute of Mental Health (NIMH); University of Washington; University...Recruiting
-
Northwell HealthNational Institute on Aging (NIA)CompletedMedication AdherenceUnited States
Clinical Trials on None (observational)
-
Indiana UniversityRecruitingDiabetes Mellitus, Type 2 | Irritable Bowel Syndrome | End Stage Renal DiseaseUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingCoagulation Disorder | Endocarditis | Valve Disease, HeartNetherlands
-
Eunice Kennedy Shriver National Institute of Child...New York State Department of Health; University at AlbanyCompletedObesity | Asthma | Blood Pressure | Developmental Delay | Allergies | Motor Delay
-
Taysha Gene Therapies, Inc.Withdrawn
-
Hugo W. Moser Research Institute at Kennedy Krieger...Active, not recruiting
-
Vanderbilt University Medical CenterMassachusetts General Hospital; Mayo Clinic; University of British Columbia; University... and other collaboratorsCompletedUrinary Tract Infections | Kidney StoneUnited States, Canada
-
Central Hospital, Nancy, FranceUnknown
-
University of BristolMedical Research Council; Wellcome Trust; NestléCompletedFeeding and Eating Disorders of Childhood | Parent-Child Relations | Parenting | Child Behavior | Eating Behavior | Child Rearing
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University-Town Hospital of Chongqing Medical UniversityWithdrawnOverweight/Obesity | Metabolic HealthChina